Catalyst Pharmaceutical Partners, Inc., is a specialty pharmaceutical company focused on in-licensing, developing and commercializing novel prescription drugs to treat rare (orphan) neurological diseases and disorders. Catalyst is an established public company that was looking for website redesign while preserving existing branding and corporate identity. The desire for a new website also coincided with a shift in the company's target therapeutic areas, requiring adjustments to overall messaging and content.
Consulting with the firm to fully understand their new directions, Axxiem designed a new site keeping a solid connection with the brand while representing some very new directions for the firm. The new site has a fresh and contemporary feel, and uses warm imagery to welcome the visitors. The project also integrates with a 3rd party Investor Relations services provider.